Summer Experience 2021 Posters
The MD Anderson Summer Experience is an umbrella program of the various academic summer programs at MD Anderson. The umbrella program provides activities such as lectures, seminars, workshops, poster presentation and networking events. This is in addition to the hand-on research training they receive from their faculty mentors. Research posters presented in this collection are a summary of the research activities of our students during their internship at MD Anderson.
- CPRTP Summer Research Experience
- CPRIT-CURE Summer Undergraduate Program
- First Year Medical Student Program
- High School Summer Program
- ITERT Undergraduate Summer Research Training Program
- Partnership for Careers in Cancer Science and Medicine
- Radiation Oncology Medical Student Summer Research Program
- Summer Imaging Research Program
- Summer Undergraduate Research Program
- U54 Partnership for Excellence in Cancer Research Summer Training Program
- University Outreach - Augustana College
- University Outreach - Baylor University
- University Outreach - Nova Southeastern University
- University Outreach - University of Notre Dame
- University Outreach - University of Texas at Rio Grande Valley
- Non-Affiliated Summer Students
-
2021 Summer Experience Program Abstracts
The University of Texas MD Anderson Cancer Center
The mission of the MD Anderson Summer Experience Program is to eliminate cancer, through training of high School, undergraduates and first year medical students to make a lasting impact on training the next generation of scientist and physicians through research and education.
The MD Anderson Summer Experience is an umbrella program that comprises 18 summer academic programs at MD Anderson.
The summer research program is an 8-10 week program that offers hands-on experience in biomedical, translational or clinical research. In this program, students are matched with a mentor from MD Anderson’s research or clinical faculty. Participants work alongside the mentor in a lab or clinic, on projects designed by faculty to reflect current research. Workshops and lectures provide opportunities to connect with faculty, residents, postdoctoral and clinical fellows, and other participants. Through the program, students assess goals related to careers in oncology research and patient care. The program culminates with a symposium in which participants present talks and posters on their research projects to peers and faculty.
-
3D MRI Data Curation for Deep Learning-based Brain Shift Simulation during Tumor Resection
Rael Memnon, Melissa Chen MD, Jeffrey Weinberg MD, Anne-Cecile Lesage PhD, and Kristy Brock PhD
- Department of Neuroradiology
- Department of Imaging Physics
-
5-Year Survival of Colorectal Cancer by Race, Gender, Stage, and Site
Taylor M. Curry; Kristin Primm PHD, MPH; and Shine Chang PhD
-
Analysis of Neural Quantification and Phenotype through Immunofluorescence Stain in Oropharyngeal Cancer
Margaret Kurop, Tongxin Xie, Jennifer Covello, Jared Burks, and Moran Amit
-
Analysis of Trends in Early-Onset Colorectal Cancer Rates using Data from the Texas Cancer Registry 1995-2017
Varun S. Rao, Jennifer S. Davis, Hui Zhao, and Edmund Scott Kopetz
-
Analyzing CFT Images to Determine Optimum Time for F- 19 MRI Acquisition in NK-cell immunotherapy of Osteosarcoma
Prabhat Kattel, Ariana Rupp, Nancy Gordon, James Bankson PhD, and Gary V. Martinez
-
Analyzing Disease Mutations in Proteins Involved in Liquid-Liquid Phase Separation
Wendy Yazmin Olivares, Sueda Cetinkaya, Raymond Zou, Sairahul Pentaparthi, Stephen Yi, and Nidhi Sahni
-
Analyzing the Effect of HADH Overexpression on Response to Immune Checkpoint Blockade
Danielle Wills, Jielin Liu, and Padmanee Sharma
-
Analyzing the Effects of MG132 on Tumor Xenografts, the Ras pathway, and HPK1 function
Mia Jane Lee and Rohan Moniruzzaman PhD
-
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Awurama Akyianu, Brian Grindel, Sunada Khadka, Florian Muller, and Steven Millward
-
A Novel Second-generation MELK specific inhibitor targets triple negative inflammatory breast cancer (TN-IBC)
Hector C. Gonzalez, Moises J. Tacam, Mohd Mughees, Juhyeon Lee, Kevin N. Dalby, and Chandra Bartholomeusz
-
A Novel Small Molecule Targeting Oncogenic miR-10b in Gastric Cancer
Paola C. Rausseo; Iman Sahnoune; and George A. Calin MD, PhD
-
Anti-B7H3 Monoclonal Antibodies Induce Natural Killer Cell and T lymphocyte- Mediated Apoptosis in Triple Negative Breast Cancer
Anudishi Tyagi and Venkata Lokesh Battula PhD
-
Anti-tumoral activity of Acetogenins derived from Soursop Fruit (Annona muricata L.) in High Grade Serous Ovarian Cancer
Roger Neuberger, Paola Amero, Cristian Rodriguez-Aguayo, Efigenia Montalvo-González, and Gabriel Lopez-Berestein
-
A Potential New Target for REST-mediated Chronic Pain
DiAngelo Gonzalez, Biji Chatterjee, Ashok Subedi, Yuying Huang, Krishna Ghosh, and Hui-Lin Pan
-
Assessing the Contribution of Activated STAT1 and STAT3 on Survival and Resistance to Platinum-Based Chemotherapy and Radiation in Head and Neck Squamous Cell Carcinoma Cells
Alina Feng, Uddalak Bharadwaj, and David Tweardy
-
Assessing the Response of Mixtures of EGFR Amplified and Non-amplified Glioma Stem Cell Lines in Response to MEK Inhibitor Treatment
Erin M. Harrison, Sabbir Khan, Veerakumar Balasubramaniyan PhD, and John F. de Groot MD
-
Assessing the Speed and Accuracy of Real-time Motion Tracking Algorithms for Abdominal Organ Motion Management in a 1.5T MR-Linac System
Mohammed Mehdi Shahid, Travis Salzillo, and Jihong Wang
-
Assessing the Tumor Mutational Burden of Patients with Pancreatic Cancer Using Cell Free DNA (cfDNA)
Brianna C. Resendiz; Daniel Lin; Bret Stephens; and Cullen M. Taniguchi MD, PhD
-
Assessment and comparison of physician-reported staging using the AJCC staging system in Head and Neck Cancer
Laura M. Pareja; Andrea De Leon; Setarah Sharafi; Travis Salzillo; Vivian Salama; and Clifton Fuller MD, PhD
-
Association between Clinical Characteristics and Pathologic Nodal Stage in Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer
Elena Rose Wernecke, Puneet Singh, Isabelle Bedrosian, Constance Albarracin, and Hui Chen
-
Association Between Quitting Smoking and Survival in Cancer Patients
Taylor Ashley Simmons, George Kypriotakis, and Janice Blalock
-
Associations Between Religious Fatalism and Modifiable Behavioral Cancer Risk Factors in Rural Cancer Survivors
Fanie M. Wabwende, Sara Nofal, Ian M. Leavitt, and Scherezade K. Mama
-
Associations Between Social Support and Depression, Stress, and Fruit and Vegetable Consumption Among African American Adults in Houston
Edom F. Kidane; Nga Nguyen; Alba Calzada; and Lorna McNeill PhD, MPH
-
A step towards true delivered dose with dose accumulation in radiotherapy
Lusmeralis Almodovar Abreu, Yulun He, Uwe Titt, Zhongxing Liao, Julianne Pollard-Larkin, Peter Balter, Radhe Mohan, and Kristy K. Brock PhD
-
ATR Inhibitor BAY 1895344 Inhibited Proliferation of Triple-Negative Breast Cancer Cells In Vitro by Arresting Cell Cycle Progression and Inducing Apoptosis
Mylah Wilson, Xuemei Xie, Jangsoon Lee, Huey Liu, and Naoto T. Ueno
-
Automated Quantification of Mitotic Figures in Patients with Melanoma
Pranathi Pilla, Phyu P. Aung, and Victor G. Prieto
-
B-cell Proximity Analysis in Early Stage Non-Small Cell Lung Carcinoma
Jay Mehta, Rossana Lazcano, Pedro da Rocha, Edwin Parra, Anthony Kang, Kasthuri Kannan, Wei Lu, Sharia Hernandez, Steven Powell, Jianling Zhou, Renganayaki Krishna Pandurengan, Ignacio Wistuba, Jay Zhang, Carmen Behrens, Linghua Wang, Humam Kadara, and Luisa M. Solis Soto
-
Cephalothin Analogs Inhibit GD3 Synthase and Target GD2+ Breast Cancer Stem-Like Cells in Triple Negative Breast Cancer
Zoe Arvanitis, Appalaraju Juggupilli PhD, Vivek Anand PhD, and Venkata Lokesh Battula PhD
-
Cerebral Blood Volume Changes During Radiotherapy May Predict Pseudoprogression versus Disease Progression for Patients with High Grade Glioma
Jodi Goldman BS; Maguy Farhat MD; Brandon J. Curl; Carlo Torres BS; Lily G. Erickson BS; Divya Yadav MD; Rituraj Upadhyay MBBS, MD; Todd A. Swanson MD, PhD; Arnold C. Paulino MD; Kristina D. Woodhouse MD; Amol J. Ghia MD; Chenyang Wang MD, PhD; Jing Li MD, PhD; Thomas H. Beckham MD, PhD; Vinodh A. Kumar MD; Benjamin M. Ellingson PhD; James P. Long PhD; and Caroline Chung MD
-
Cervical Cancer Incidence Disparities in the United States (2001-2018)
Kevin J. Ortiz-Ramos; Haluk Damgacioglu; Ashish A. Deshmukh; and Elizabeth Y. Chiao MD, MPH
-
Characterization of Invasive Streptococci Isolated in a Nosocomial Outbreak with Illumina and Nanopore Whole Genome Sequencing
Mark Ming-Shen Li; Xiaojun Liu PhD, MEd; Peter Hu PhD; and Awdhesh Kalia PhD
School of Health Professions
-
Characterization of Small Molecules that Degrade YAP1 Protein in Cancer
Sudili M. Fernando, Praveen Barrodia, and Kunal Rai
-
Characterizing Disease Related Mutations in Proteins Involved in Liquid-Liquid Phase Separation
Sueda Hafsa Cetinkaya, Raymond Zou, Sairahul Pentaparthi, David Shih, Wendy Olivares, Stephen Yi, and Nidhi Sahni
-
Characterizing human enteriods for response by FG-4592
Maya Ferrell; Neeraj Kumari; Carolina J. Garcia; and Cullen M. Taniguchi MD, PhD
-
Characterizing infiltrating monocytes in anti-PD-1/CTLA-4 immunotherapy resistant NSCLC tumors
Karina Flores, Bertha Leticia Rodriguez, Jessica Marie Konen, Limo Chen, and Don Gibbons
-
Characterizing the Abraxas/BRCA1 Interaction in the Control of DNA Double Strand Breaks
Grace Marie Murphy, Xiao Wu, Shengfeng Xu, and Bin Wang
-
Classifying the Microenvironment of Mesothelioma
Cole A. Ponsi, Hsin-Yi Lu, Carlos Ramos, Jacqueline Oliva, Katarzyna J. Tomczak, Boris Sepesi, and Cara Haymaker
-
Clinical Relevance of MDM2 Testing in Lipomatous Tumors of the Extremities
Tanner Hafen and Valerae Lewis MD
-
Clonal Interdependency between Wild-type and Mutant p53 AML Abrogates BCL-2 Inhibitor-Mediated Apoptosis
Atreyu Samuel Balasundaram
-
Colorectal and Breast Cancer Screening in the U.S. during the COVID-19 Pandemic
Rosheem C. Browne MS; Jiangong Niu PhD; Daria Zorzi MD; and Sharon H. Giordano MD, MPH
-
Colorectal Cancer Screening Guidelines: Analysis of the 2019 National Health Interview Survey (NHIS)
Isabela M. Bumanlag BS; Joseph Abi Jaoude MD; Ethan B. Ludmir MD; and Cullen M. Taniguchi MD, PhD
-
Combination of ATR Inhibition and X-Ray Irradiation Radiosensitizes Cancer Cells
Nischal Ada, David Martinus, David Flint, Gabriel Sawakuchi, and Simona Shaitelman
-
Combination therapy of DNA repair inhibitors and ionizing radiation to enhance DNA damage in 4T1 murine breast cancer and H1299 non-small cell human lung carcinoma cell lines
Vijay Patel, Broderick X. Turner, Scott J. Bright, David B. Flint, David Martinus, Mandira Ben Kacem, Simona F. Shaitelman, and Gabriel Sawakuchi
